Last reviewed · How we verify
myocardial infarctions
Approved treatments
- olmesartan medoxomil-hydrochlorothiazide · Cosette
Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- myocardial infarctions patent landscape — cliff calendar, originator estates, attackable patents
- myocardial infarctions treatment landscape brief
- myocardial infarctions treatment updates RSS
Frequently asked questions about myocardial infarctions
What drugs treat myocardial infarctions?
Tracked treatments include olmesartan medoxomil-hydrochlorothiazide.
What is the treatment for myocardial infarctions?
Standard treatment for myocardial infarctions includes olmesartan medoxomil-hydrochlorothiazide. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: myocardial infarctions patent cliff · myocardial infarctions CI report
- Treatment: olmesartan medoxomil-hydrochlorothiazide · Cosette
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing